Literature DB >> 10882748

Interleukin-15 induces rapid tyrosine phosphorylation of STAT6 and the expression of interleukin-4 in mouse mast cells.

A Masuda1, T Matsuguchi, K Yamaki, T Hayakawa, M Kubo, W J LaRochelle, Y Yoshikai.   

Abstract

Interleukin (IL)-4 plays an important role in the differentiation of naive T helper (Th) cells into Th2. Mast cells can produce a significant amount of IL-4 and have been proposed to play a major role in the induction of Th2 responses. Recently, it has been reported that mast cells have a distinct IL-15 receptor system different from that of T or natural killer cells. In the present study, we demonstrated that IL-15 induced IL-4 production from a mouse mast cell line, MC/9, and bone marrow-derived mast cells. IL-4 mRNA expression was increased by IL-15, suggesting that IL-15 promotes IL-4 expression at the transcriptional level. In these mast cells, signal transducer and activator of transcription (STAT) 6 were rapidly tyrosine-phosphorylated in response to IL-15. In MC/9 cells, the expression of a C-terminally truncated dominant negative form of STAT6 significantly suppressed the IL-4 mRNA up-regulation by IL-15, suggesting that STAT6 activation is essential for the IL-15-mediated IL-4 production. Additionally, tyrosine phosphorylation of Tyk2 was rapidly increased by IL-15 treatment in this cell line. Altogether, our results suggest that IL-15 plays an important role in stimulating early IL-4 production in mast cells that may be responsible for the initiation of Th2 response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882748     DOI: 10.1074/jbc.M910290199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  The Immunologic Mechanisms of Eosinophilic Esophagitis.

Authors:  David A Hill; Jonathan M Spergel
Journal:  Curr Allergy Asthma Rep       Date:  2016-02       Impact factor: 4.806

2.  Methylation and microRNA-mediated epigenetic regulation of SOCS3.

Authors:  Chandra S Boosani; Devendra K Agrawal
Journal:  Mol Biol Rep       Date:  2015-04       Impact factor: 2.316

3.  Expression of interleukin-15 in mouse and human atherosclerotic lesions.

Authors:  D M Wuttge; P Eriksson; A Sirsjö; G K Hansson; S Stemme
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

4.  Tumor cell-expressed IL-15Rα drives antagonistic effects on the progression and immune control of gastric cancer and is epigenetically regulated in EBV-positive gastric cancer.

Authors:  Jing Wei; Chen Guo; Xiang An; Wenxuan Miao; Chenli Zhang; Binsheng Wang; Wei Cai; Min Li; Fangfang Zhang
Journal:  Cell Oncol (Dordr)       Date:  2020-08-07       Impact factor: 6.730

Review 5.  Molecular pathways: interleukin-15 signaling in health and in cancer.

Authors:  Anjali Mishra; Laura Sullivan; Michael A Caligiuri
Journal:  Clin Cancer Res       Date:  2014-04-15       Impact factor: 12.531

Review 6.  Regulating the immune system via IL-15 transpresentation.

Authors:  Eliseo F Castillo; Kimberly S Schluns
Journal:  Cytokine       Date:  2012-07-12       Impact factor: 3.861

Review 7.  Regulation of STATs by polycystin-1 and their role in polycystic kidney disease.

Authors:  Thomas Weimbs; Erin E Olsan; Jeffrey J Talbot
Journal:  JAKSTAT       Date:  2013-04-01

8.  Mast cell/IL-4 control of Francisella tularensis replication and host cell death is associated with increased ATP production and phagosomal acidification.

Authors:  A R Rodriguez; J-J Yu; A K Murthy; M N Guentzel; K E Klose; T G Forsthuber; J P Chambers; M T Berton; B P Arulanandam
Journal:  Mucosal Immunol       Date:  2010-09-22       Impact factor: 7.313

Review 9.  Mast cell function: a new vision of an old cell.

Authors:  Elaine Zayas Marcelino da Silva; Maria Célia Jamur; Constance Oliver
Journal:  J Histochem Cytochem       Date:  2014-07-25       Impact factor: 2.479

10.  Detection of a functional hybrid receptor gammac/GM-CSFRbeta in human hematopoietic CD34+ cells.

Authors:  J Giron-Michel; M Fogli; A Gaggero; S Ferrini; A Caignard; D Brouty-Boye; S Baouz; M-C Le Bousse-Kerdiles; B Peault; M van Dijk; S Bulfone-Paus; D Durali; S Chouaib; B Azzarone
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.